Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia

McConeghy, K. W., Bleasdale, S. C., Rodvold, K. A. · 2013 · Clinical Infectious Diseases

Abstract

The high prevalence of methicillin resistance among Staphylococcus aureus bacteremias leads to common use of vancomycin as empirical therapy. However, investigators have reported poor outcomes with vancomycin treatment for methicillin-susceptible Staphylococcus aureus bacteremia. We review the evidence supporting empirical combination of both vancomycin and a β-lactam agent for Staphylococcus aureus bacteremia. Vancomycin therapy for methicillin-susceptible Staphylococcus aureus bacteremia is associated with 2-3 times the risk of morbidity and mortality compared to an antistaphylococcal penicillin (oxacillin and nafcillin) or first-generation cephalosporin (cefazolin). De-escalation of empirical vancomycin to definitive β-lactam therapy still appears inferior to initial β-lactam therapy. Although there is no clinical trial supporting combination therapy, a scientific rationale for benefit exists and should be weighed against the risks (adverse events, antibiotic resistance, and cost) of additional pharmacotherapy. The empirical combination of vancomycin and a β-lactam (either nafcillin, oxacillin, or cefazolin) for staphylococcal bacteremia may improve infection-related clinical outcomes.

Overview

Integrity signals

Registry

Crossref · 10.1093/cid/cit560

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Research works printed but not linked: 3

  1. 2011, Clinical Infectious Diseases, 531, S4
  2. Rudolph, 1973, JAMA, 223, 499, 10.1001/jama.1973.03220050011003 · doi:10.1001/jama.1973.03220050011003
  3. 1971, Postgraduate Medical Journal, 47, 64

Cited by

See all 90

Metadata

Authors
McConeghy, K. W., Bleasdale, S. C., & Rodvold, K. A.
Affiliations
University of Illinois Chicago (US)
Venue
Clinical Infectious Diseases
Published
2013-08-28
Volume
57
Issue
12
Pages
1760-1765
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2157481885
Cited by
90
References
47
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 8 · 2016: 10 · 2015: 12 · 2014: 10 · 2013: 1
FWCI
1.42
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
Pfizer
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords
vancomycin, beta-lactam antibiotics, Staphylococcus aureus bacteremia, methicillin-susceptible Staphylococcus aureus, oxacillin, nafcillin, cefazolin, de-escalation, antibiotic adverse events, antibiotic costs
MeSH terms
Anti-Bacterial Agents, Drug Therapy, Combination, Humans, Staphylococcal Infections, Vancomycin, Cohort Studies, Bacteremia, beta-Lactams, Methicillin-Resistant Staphylococcus aureus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia. https://app.cochat.ai/papers/10.1093/cid/cit560
The paper
McConeghy, K. W., Bleasdale, S. C., & Rodvold, K. A. (2013). The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cit560

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.